NCT02296398View on ClinicalTrials.gov

Long-term Use of Romidepsin in Patients With CTCL

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Cutaneous T-cell Lymphoma
Interventions
DRUG

Romidepsin

Received romidepsin per standard of care or through a clinical trial for more than one cycle

Trial Locations (1)

60611

Northwestern University Dermatology Department, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02296398 - Long-term Use of Romidepsin in Patients With CTCL | Biotech Hunter | Biotech Hunter